Lopinavir/Ritonavir 200mg/50mg Tablets

Inhibitor of the HIV-1 and HIV-2 proteases. Inhibition of HIV protease prevents cleavage of the gag-pol polyprotein resulting in the production of immature, non-infectious virus.

Share Now

Enquire Now
NameLopinavir/Ritonavir
DescriptionInhibitor of the HIV-1 and HIV-2 proteases. Inhibition of HIV protease prevents cleavage of the gag-pol polyprotein resulting in the production of immature, non-infectious virus.
Active IngredientLopinavir/Ritonavir
Indication
  • A fixed dose combination medication for the treatment and prevention of Anti Retrovirals as well as HIV/AID.
  • World Health Organization’s List of Essential Medicines.
  • The safest and most effective medicines needed in a health system.
  • Was approved by the USFDA for the ARV/HIV/AIDs
  • When used on patients with Covid 19 they showed significant signs of improvement.
  • Being considered tested and used for the treatment of the emerging novel coronavirus (COVID-19)
  • Have fairly good inhibitory effects on SARS-CoV-2
  • A retrospective comparative analysis completed by the WHO has revealed that Lopinavir/Ritonavir was successful in acute respiratory distress syndrome or death reduction from 28% to 2.4%
Strengths200mg/50mg Tablets
Business PartnerMylan
OriginIndia

Related Product

Related products